The amplification of TPX2 is a potential biomarker of oxaliplatin-susceptibility in colorectal cancer

被引：0
|
作者：
Ueno, Shohei [1 ]
Isobe, Taichi [2 ]
Taguchi, Ryosuke [1 ]
Tsuchihashi, Kenji [2 ]
Ariyama, Hiroshi [2 ]
Akashi, Koichi [3 ]
Baba, Eishi [4 ]
机构：
[1] Kyushu Univ, Dept Med Biosyst Sci, Fac Med, Fukuoka, Fukuoka, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka, Fukuoka, Japan
[3] Kyushu Univ, Dept Internal Med 1, Fac Med Sci, Fukuoka, Fukuoka, Japan
[4] Kyushu Univ, Dept Oncol & Social Med, Grad Sch Med Sci, Fukuoka, Fukuoka, Japan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-2281
引用
收藏
页码：1449 / 1449
页数：1
相关论文
共 50 条
  • [1] The amplification of TPX2 is a potential biomarker of oxaliplatin-sensitivity of colorectal cancers (CRCs) with CIN phenotype
    Ueno, Shohei
    Isobe, Taichi
    Taguchi, Ryosuke
    Tsuchihashi, Kenji
    Akashi, Koichi
    Baba, Eishi
    CANCER RESEARCH, 2024, 84 (06)
  • [2] Colorectal cancers (CRCs) with TPX2 amplification is highly sensitive to oxaliplatin
    Ueno, Shohei
    Isobe, Taichi
    Taguchi, Ryosuke
    Yamaguchi, Kyoko
    Tsuchihashi, Kenji
    Akashi, Koichi
    Baba, Eishi
    CANCER SCIENCE, 2025, 116 : 1882 - 1882
  • [3] Therapeutic targeting of the TPX2/TTK network in colorectal cancer
    Shaath, Hibah
    Vishnubalaji, Radhakrishnan
    Elango, Ramesh
    Velayutham, Dinesh
    Jithesh, Puthen Veettil
    Alajez, Nehad M.
    CELL COMMUNICATION AND SIGNALING, 2023, 21 (01)
  • [4] Upregulation of TPX2 and KIF20A in colorectal cancer
    Ghadiri, Fatemeh
    Tajamolian, Masoud
    Mollanoori, Hasan
    Babakhanzadeh, Emad
    Kargar, Saeed
    Javid, Ameneh
    Dehghani, Mohmmadreza
    BIOMEDICAL RESEARCH AND THERAPY, 2025, 12 (02): : 7168 - 7183
  • [5] Therapeutic targeting of the TPX2/TTK network in colorectal cancer
    Hibah Shaath
    Radhakrishnan Vishnubalaji
    Ramesh Elango
    Dinesh Velayutham
    Puthen Veettil Jithesh
    Nehad M. Alajez
    Cell Communication and Signaling, 21
  • [6] TPX2 as a novel prognostic biomarker for hepatocellular carcinoma
    Liu, Qingquan
    Tu, Kangsheng
    Zhang, Hongyong
    Zheng, Xin
    Yao, Yingmin
    Liu, Qingguang
    HEPATOLOGY RESEARCH, 2015, 45 (08) : 906 - 918
  • [7] Validation of TPX2 as a Potential Therapeutic Target in Pancreatic Cancer Cells
    Warner, Steven L.
    Stephens, Bret J.
    Nwokenkwo, Stanley
    Hostetter, Galen
    Sugeng, Anastasia
    Hidalgo, Manuel
    Trent, Jeffery M.
    Han, Haiyong
    Von Hoff, Daniel D.
    CLINICAL CANCER RESEARCH, 2009, 15 (21) : 6519 - 6528
  • [8] TPX2 Serves as a Cancer Susceptibility Gene and Is Closely Associated with the Poor Prognosis of Endometrial Cancer
    Wang, Jun
    Zheng, Hua
    He, Hui
    Meng, Shuying
    Han, Yatian
    Su, Zhe
    Yan, Hanbing
    Zhang, Yanan
    GENETICS RESEARCH, 2022, 2022
  • [9] Prognostic significance of TPX2 and NIBP in esophageal cancer
    Sui, Chao
    Song, Zhifang
    Yu, Huimin
    Wang, Haiwen
    ONCOLOGY LETTERS, 2019, 18 (04) : 4221 - 4229
  • [10] miR-485-3p suppresses colorectal cancer via targeting TPX2
    Taherdangkoo, K.
    Nezhad, Kazemi S. R.
    Hajjari, M. R.
    Birgani, Tahmasebi M.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2020, 121 (04): : 302 - 307
12345